Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novo Nordisk A/S (NYSE:NVO)

50.91
Delayed Data
As of Nov 17
 0.00 / 0.00%
Today’s Change
30.89
Today|||52-Week Range
51.05
+41.97%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Operating ActivitiesNet Income / Starting Line4.5B4.7B5.2B5.6B
 
 
 
 
 
Depreciation473.5M495.6M437.7M454.7M
 
 
 
 
 
Total Other Cash Flow-291.1M808.8M388.3M1.6B
 
 
 
 
 
Funds From Operations4.7B6.0B6.0B7.7B
 
 
 
 
 
Funds From/For Other Operating Expenses47.3M380.7M319.1M549.8M
 
 
 
 
 
Net Cash Flow - Operating Activities4.6B5.6B5.7B7.2B
 
 
 
 
 
 
InvestingIncrease In Investments0.000.00-524.0M-78.7M
 
 
 
Decrease In Investments149.8M401.8M226.6M306.0M
 
 
 
 
 
Capital Expenditures-577.5M-707.2M-772.8M-1.0B
 
 
 
 
 
Fixed Asset Disposal5.5M709.0K342.9M1.0M
 
 
 
 
 
Other Investing - Uses0.00-61.2M0.00-16.6M
 
 
 
Other Investing - Sources0.000.000.003.4M
 
 
Net Cash Flow Investing-494.6M-365.8M-902.1M-1.0B
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale0.000.000.000.00--
Common Preferred Redeemed-2.5B-2.6B-2.5B-2.2B
 
 
 
 
 
Common Dividends-1.7B-2.1B-1.9B-3.5B
 
 
 
 
 
Cash Dividends Paid - Total-1.7B-2.1B-1.9B-3.5B
 
 
 
 
 
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing-4.2B-4.7B-4.5B-5.8B
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-12.5M12.1M12.7M-3.9M
 
 
 
 
 
 
Net Change In Cash-83.8M548.6M308.9M391.0M